Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Board fully replaced NBB
No director from three years ago is still active according to annual account 2025.
Financials
Financial year 2025
EXENDO EPIGENOMICS from Herentals, company number BE0838650023, closed financial year 2025 with a result of € 224,361 after tax. For that financial year EXENDO EPIGENOMICS recorded a gross margin of € 327,814 and equity of € 307,434. Compared with financial year 2024, the result moved from € 308,392 to € 224,361. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 31, 2026.
€ 307,434
▲ 36% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 224,361
▼ 27% vs 2024
Profit after tax over the fiscal year.
€ 15,063
▼ 82% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 142,857 paid out
64 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
€ 10,602
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 4,228
▼ 51% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 8,464
▼ 35% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 9,994
▲ 136% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 333,933 | € 341,920 | € 421,571 | € 327,814 | ▼ 22% |
| Profit after taxes | € 249,873 | € 249,693 | € 308,392 | € 224,361 | ▼ 27% |
| Equity | € 101,415 | € 199,680 | € 225,930 | € 307,434 | ▲ 36% |
| Total debts | € 55,443 | € 10,464 | € 103,601 | € 20,896 | ▼ 80% |
| Cash | € 8,708 | € 8,623 | € 84,554 | € 15,063 | ▼ 82% |
| Retained profit | € 82,815 | € 181,080 | € 207,330 | € 288,834 | ▲ 39% |
| Dividend | € 284,000 | € 151,429 | € 282,143 | € 142,857 | ▼ 49% |
| Balance sheet total | € 156,858 | € 210,144 | € 329,530 | € 328,329 |
Key figures of EXENDO EPIGENOMICS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to EXENDO EPIGENOMICS?
What happened at EXENDO EPIGENOMICS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 224,361 (▼ 27% vs 2024). Source: NBB ↗
- Peter Dücker became a director. NBB
- Luc Flamend stepped down as director. NBB
- New establishment in Herentals. KBO
- Luc Flamend became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 249,873 profit in 2022 to € 224,361 profit in 2025.
Paid € 343,623 in corporate taxes since 2022.
Best year ever: 2024, with € 308,392 profit.
Paid out € 860,429 in dividends to the owners in total.
A new publication or filing at EXENDO EPIGENOMICS? We notify you, reason included.
Follow EXENDO EPIGENOMICSDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind EXENDO EPIGENOMICS is Peter Dücker.
Directors
According to the 2025 annual accounts
Peter Dücker
Director
since 2025
Luc Flamend
Director
since 2011 · until 2025
Establishments
Establishment units
Physical locations of this company
Diamantstraat (HRT) 8
2200 Herentals
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0838.650.023
- VAT number
- BE 0838.650.023
- Registered office
- Diamantstraat (HRT) 8, 2200 Herentals
- Names & denominations
- EXENDO EPIGENOMICS · EXENDO
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 11 August 2011
- Peppol
- Active · Active since 27 Mar 2026
- Activities · NACE
Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen
Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels
Overige detailhandel in voedingsmiddelen, neg
Overige detailhandel in voedingsmiddelen in gespecialiseerde winkels, n.e.g.